Vis enkel innførsel

dc.contributor.authorCarlsson, Sofia
dc.contributor.authorMidthjell, Kristian
dc.contributor.authorGrill, Valdemar
dc.date.accessioned2019-10-24T12:35:51Z
dc.date.available2019-10-24T12:35:51Z
dc.date.created2013-09-30T11:37:36Z
dc.date.issued2013
dc.identifier.citationNorsk Epidemiologi. 2013, 23 (1), 39-44.nb_NO
dc.identifier.issn0803-2491
dc.identifier.urihttp://hdl.handle.net/11250/2624181
dc.description.abstractLADA (latent autoimmune diabetes in adults) may be the most common form of autoimmune diabetes and thus encompasses a significant proportion of the diabetic population. Still, knowledge about this common form of diabetes is limited. In this paper we give an overview of some aspects of LADA, primarily using data from the Nord-Trøndelag Health Study (HUNT). In HUNT, LADA accounts for 7% of all incident cases of diabetes in adults. Data from HUNT indicate that risk factors for LADA include overweight, physical inactivity, family history of diabetes and low psychosocial well-being. Risk factors thus seem to be largely similar to those of type 2 diabetes which suggests a partially shared pathogenesis, in spite of the autoimmune nature of LADA. With regard to genetic factors LADA may be a genetic mix of type 1 and type 2 diabetes, as LADA patients seem to have an increased prevalence of HLA haplotypes linked to type 1 diabetes, and possibly also genes associated with type 2 diabetes. Patients with LADA are at increased mortality risk, primarily from cardiovascular disease. The excess risk seems to be linked to poor glycemic control rather than metabolic risk factors. These results emphasise the importance of optimal treatment modalities to improve survival in LADA. Documentation of optimal treatment for LADA is still lacking and there is an urgent need for studies in this field.nb_NO
dc.language.isoengnb_NO
dc.publisherNorsk forening for epidemiologi, NOFEnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleLADA (latent autoimmune diabetes in adults) in Norway - occurence, risk factors, treatment and complications :nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber39-44nb_NO
dc.source.volume23nb_NO
dc.source.journalNorsk Epidemiologinb_NO
dc.source.issue1nb_NO
dc.identifier.doi10.5324/nje.v23i1.1601
dc.identifier.cristin1053749
dc.description.localcodeCopyright (c) 2015 Norsk epidemiologi Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.nb_NO
cristin.unitcode194,65,20,0
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal